INTERNATIONAL PATENT: COUR PHARMACEUTICALS DEVELOPMENT COMPANY INC. FILES APPLICATION FOR "TOLERIZING IMMUNE MODIFYING NANOPARTICLES FOR TREATMENT OF NARCOLEPSY"

GENEVA, Jan. 28 -- COUR PHARMACEUTICALS DEVELOPMENT COMPANY INC. (8045 Lamon Avenue, #1202Skokie, IL 60077) filed a patent application (PCT/US2025/037936) for "TOLERIZING IMMUNE MODIFYING NANOPARTICLES FOR TREATMENT OF NARCOLEPSY" on Jul 16, 2025. With publication no. WO/2026/019942, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MCCARTHY, Derrick (c/o Cour Pharmaceuticals Development Company Inc.8045 Lamon Avenue, #1202Skokie, IL 60077)

Abstract: The present application is directed, in general, to tolerizing immune med...